The TGF-beta - SMAD pathway is inactivated in cronic lymphocytic leukemia cells

Autor: Matveeva A, Kovalevska L, Kholodnyuk I, Ivanivskaya T, Kashuba E

Publikováno v: Europe PubMed Central

To study the status of the tumor growth factor beta (TGFB) pathway in chronic lymphocytic leukemia (CLL) cells and to uncover molecular details underlying CLL cell genesis.The study was conducted on peripheral blood samples of patients with CLL using

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::558369a112952e07bf7e28ccf402dbd9
https://pubmed.ncbi.nlm.nih.gov/29284776

CD150 and CD180 are involved in regulation of transcription factors expression in chronic lymphocytic leukemia cells.

Autor: Gordiienko I; Department of Molecular and Cellular Pathobiology, R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv 03022, Ukraine., Shlapatska L; Department of Molecular and Cellular Pathobiology, R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv 03022, Ukraine., Kholodniuk VM; Department of Molecular and Cellular Pathobiology, R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv 03022, Ukraine., Kovalevska L; Department of Molecular and Cellular Pathobiology, R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv 03022, Ukraine., Ivanivskaya TS; Department of Oncohematology, R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv 03022, Ukraine., Sidorenko SP; Department of Molecular and Cellular Pathobiology, R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv 03022, Ukraine.

Publikováno v: Experimental oncology [Exp Oncol] 2017 Dec; Vol. 39 (4), pp. 291-298.